Location History:
- CH-1208 Geneva, CH (2003)
- Geneva, CH (2011 - 2017)
Company Filing History:
1 out of 8 
2 out of 832,761 Years Active: 2003-2017
Title: Jacques Schrenzel: Innovator in Molecular Detection
Introduction
Jacques Schrenzel is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of molecular detection, particularly in the medical and biological sciences. With a total of three patents to his name, Schrenzel's work focuses on innovative methods for separating and detecting target molecules.
Latest Patents
One of Schrenzel's latest patents involves a method for separating target molecules or particles from fibrinogen-containing samples, including blood components. This method includes trapping target molecules in a fibrin network, retracting the fibrin network to form a clot, and subsequently separating the clot from the surrounding medium. Another significant patent describes a method for the detection and quantification of methicillin-resistant bacteria. This process involves several steps, including the use of Anti-Protein A antibodies, lysis of the bacteria to release DNA, and amplification of target DNA sequences for detection.
Career Highlights
Throughout his career, Jacques Schrenzel has worked with various companies, including Spinomix S.A. His innovative approaches have led to advancements in diagnostic methods, particularly in the detection of antibiotic-resistant pathogens.
Collaborations
Schrenzel has collaborated with notable individuals in his field, including Patrice Francois and Amar Rida. These collaborations have contributed to the development of his patented methods and have enhanced the impact of his work in molecular detection.
Conclusion
Jacques Schrenzel's contributions to the field of molecular detection through his innovative patents highlight his role as a leading inventor. His work continues to influence advancements in medical diagnostics and the detection of resistant bacteria.